Aug 01, 2023 / 09:00AM GMT
Jasper Eenhorst - Redcare Pharmacy NV - CFO
Yeah, good morning, everybody. Welcome from Sevenum, the Netherlands. It's 11:00 local time here, and Monica Ambrosi and myself are very happy to be able to share with you today's numbers. We will present them and it will be followed by a Q&A session as always.
Today, August 1, is also the first official working day for Olaf Heinrich, the new CEO. And as of the coming quarter 3, Olaf and myself will host the presentation together. Today, very happy that Monica is again here just like past quarter.
So presenting from here, the agenda is straightforward. It's the same structure as always, starting with the financial performance of quarter two. And with that, of the first half of 2023, an update on business and strategy. And then, our outlook for the future financial performance and the Q3 -- sorry, the H1-2023 financial highlights.
Continued fast growth, and perhaps that's a little bit soft title because actually, our growth was 46% in quarter two. And with that, 34% over the first six months of this year compared to last year. If
Q2 2023 Redcare Pharmacy NV Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers